Related Experiment Video
Updated: Jul 18, 2025

08:04
Pancreatic Tissue Dissection to Isolate Viable Single Cells
Published on: May 26, 2023
2.8K
Coordinated single-cell tumor microenvironment dynamics reinforce pancreatic cancer subtype
Ki Oh1, Yun Jae Yoo1, Luke A Torre-Healy1
1Department of Biomedical Informatics, Stony Brook University, Stony Brook, NY, USA.
Nature Communications
|August 26, 2023
Summary
This study reveals distinct pancreatic ductal adenocarcinoma (PDAC) immune and stromal landscapes. Activated stroma correlates with immunosuppressive cells, while normal stroma recruits anti-tumor immune cells, offering new therapeutic targets.
Area of Science:
- Oncology
- Immunology
- Bioinformatics
Background:
- Pancreatic ductal adenocarcinoma (PDAC) bulk analyses are confounded by the complex tumor microenvironment (TME).
- Distinct tumor and stroma subtypes with prognostic value have been identified, but the signaling pathways driving these landscapes remain unclear.
- Understanding tumor-TME interdependence is crucial for developing effective PDAC therapies.
Purpose of the Study:
- To integrate single-cell RNA sequencing data to create a comprehensive PDAC atlas.
- To elucidate the signaling interactions governing distinct immune and stromal landscapes in PDAC.
- To provide tools for future research, including a cell type classifier and a signaling factor atlas.
Main Methods:
- Integration of 92 single-cell RNA-seq samples from seven independent PDAC studies.
- Comparative analysis of immune cell populations and stromal characteristics between different PDAC subtypes.
- Validation of identified signaling factors in mouse models.
Main Results:
- Patients with activated stroma exhibit increased myofibroblastic and immunogenic fibroblasts, M2-like macrophages, and regulatory T-cells.
- Patients with 'normal' stroma show M1-like macrophage recruitment and elevated effector and exhausted T-cells.
- A reproducible PDAC atlas and a pretrained cell type classifier were developed.
Conclusions:
- The study highlights distinct immune profiles associated with activated versus normal stroma in PDAC.
- These findings provide insights into the signaling networks that shape the PDAC TME.
- The developed resources facilitate further investigation into PDAC heterogeneity and therapeutic strategies.

